<DOC>
	<DOCNO>NCT02565784</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Restylane Lidocaine Restylane Perlane Lidocaine first second treatment use facial augmentation Asian population .</brief_summary>
	<brief_title>Safety Efficacy Restylane Lidocaine Restylane Perlane Lidocaine Facial Augmentation Asian Population</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subjects intent undergo facial filler treatment either volume loss contour Subjects require treatment two four predefined area face ( upper cheek , nasolabial fold , temple , nose chin ) Require 35 ml investigational product achieve clinically meaningful improvement appearance Facial appearance Han Chinese Nonpregnant , nonbreast feed female Signed informed consent Previous facial surgery ( e.g . rhinoplasty ) permanent implant area treat . History chronic sinusitis rhinitis ( applicable subject inject nose ) . Subjects need use heavy glass study ( applicable subject inject nose ) . Previous tissue augment therapy contour permanent filler fat injection facial area . Previous treatment Hyaluronic acid ( HA ) filler Restylane Skinboosters facial area within 12 month treatment . Previous treatment nonHA filler CaHA ( Calcium Hydroxylapatite ) PLLA ( Poly LLactic Acid ) within 24 month treatment . Previous revitalization neurotoxin facial area within six ( 6 ) month treatment . Previous tissue revitalization treatment laser light , mesotherapy , chemical peel dermabrasion facial area within six ( 6 ) month treatment . Any medical condition , opinion investigator , would make subject unsuitable inclusion ( e.g . chronic , relapse hereditary disease may interfere outcome study ) .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>